Search Results 881-890 of 18154 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  2. A Study Of Investigational Immunotherapy To Determine The Safety And Effectiveness Of Nivolumab And Daratumumab, With Or Without Pomalidomide And Dexamethasone, In Patients With Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    Prior treatment with anti CD38 monoclonal antibodies. Treatment with ... History of Grade 4 anaphylactic reaction to monoclonal antibody therapy.

  3. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    The anti-mucosal addressin cell adhesion molecule (MAdCAM) monoclonal antibody (renamed SHP647) was effective in ulcerative colitis but not in Crohn's disease ...

  4. Mayo Clinic Q and A: The connection between skin care and transplant

    Monoclonal antibody therapy for COVID-19 safe for transplant patients. Related Articles. Mayo Clinic Q&A: Does a bone tumor always mean cancer? featured image.

  5. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  6. Evaluation Of CRS-207 With Pembrolizumab In Previously Treated MPM - Mayo Clinic

    Active secondary malignancy; Prior anti-cancer monoclonal antibody within 4 weeks prior to first dose of study drug, or not recovered from adverse effects ...

  7. Mayo Clinic launches neutralizing antibody test to advance COVID-19 therapies

    The neutralizing antibody test provides semi-quantitative detection of total neutralizing antibodies against the SARS-CoV-2 spike glycoprotein in human serum.

  8. Publications - Aditya K. Ghosh, M.D. - Mayo Clinic

    Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19). Obstet Gynecol 2022 Apr 1; 139 (4):616 ...

  9. Further Cardiovascular Outcomes Research With PCSK9 Inhibition In Subjects With Elevated Risk - Mayo Clinic

    Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol ...

  10. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...